RIYADH — The World Well being Group (WHO) introduced that Saudi Arabia, represented within the Saudi Meals and Drug Authority (SFDA), has reached maturity degree 4 (ML4) for medicines and vaccines regulation.
Attaining maturity degree 4, the best degree of WHO’s classification for regulatory authorities, displays SFDA’s sound and credible necessities aimed toward guaranteeing drug security and enhancing common well being.
The Assistant Director-Basic for Entry to Medicines and Well being Merchandise on the WHO, Dr. Yukiko Nakatani, stated this achievement by SFDA constitutes a major milestone for the Kingdom and the area.
She added that SFDA is the primary nationwide regulatory authority within the Japanese Mediterranean and the third worldwide to attain ML4 primarily based on the benchmarking train of the WHO.
“This achievement additional solidifies the longstanding partnership between the WHO and the Saudi authorities in working in direction of the objectives of complete common well being protection and sustainable growth,” emphasised Nakatani.
Attaining ML4 additionally strengthens the collaborative efforts of each events to make sure and improve entry to high-quality, protected, and efficient medical merchandise. It additionally helps the worldwide market entry of regionally manufactured drugs. — SPA